New Therapeutic Concepts Using Artificial Oxygen Carriers

  • D. R. Spahn
Conference paper


Artificial oxygen (O2) carriers aim at improving O2 transport and O2 unloading to the tissue. Artificial O2 carriers thus may be used as an alternative to allogeneic blood transfusions or to improve tissue oxygenation and the function of organs with marginal O2 supply. The aim of the present article is to describe the artificial O2 carriers that have currently been evaluated, to summarize their efficiency and to discuss potential side effects.


Oxygen Carrier Hydroxyethyl Starch Therapeutic Concept Hemoglobin Solution Improve Tissue Oxygenation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Spahn DR, Leone BJ, Reves JG, Pasch T (1994) Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions. Anesth Analg 78:1000–1021PubMedCrossRefGoogle Scholar
  2. 2.
    Vlahakes GJ, Lee R, Jacobs EE, LaRaia PJ, Austen WG (1990) Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 100:379–388PubMedGoogle Scholar
  3. 3.
    Standi T, Lipfert B, Reeker W, Schulte am Esch J, Lorke DE (1996) Akute Auswirkungen eines kompletten Blutaustauschs mit ultragereinigter Hämoglobinlösung oder Hydroxyäthylstärke auf Leber und Niere im Tiermodell. Anasthesiol Intensivmed Notfallmed Schmerzther 31:354–361CrossRefGoogle Scholar
  4. 4.
    Siegel JH, Fabian M, Smith JA, Costantino D (1997) Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 42:199–212PubMedCrossRefGoogle Scholar
  5. 5.
    Xu L, Sun L, Rollwagen FM, Li Y, Pacheco ND, Pikoulis E, Leppaniemi A, Soltero R, Burris D, Malcolm D, Nielsen TB (1997) Cellular responses to surgical trauma, hemorrhage, and resuscitation with diaspirin cross-linked hemoglobin in rats. J Trauma 42:32–41PubMedCrossRefGoogle Scholar
  6. 6.
    Hebert PC, Hu LQ, Biro GP (1997) Review of physiologic mechanisms in response to anemia. Can Med Assoc J 156:27–40Google Scholar
  7. 7.
    Fitzgerald RD, Martin CM, Dietz GE, Doig GS, Potter RF, Sibbald WJ (1997) Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 25:726–732PubMedCrossRefGoogle Scholar
  8. 8.
    Standi T, Horn P, Wilhelm S, Greim C, Freitag M, Freitag U, Sputtek A, Jacobs E, Schulte am Esch J (1996) Bovine haemoglobin is more potent than autologous red blood cells in restoring muscular tissue oxygenation after profound isovolaemic haemodilution in dogs. Can J Anaesth 43:714–723CrossRefGoogle Scholar
  9. 9.
    Horn EP, Standi T, Wilhelm S, Jacobs EE, Freitag U, Freitag M, Esch JSA (1997) Bovine hemoglobin increases skeletal muscle oxygenation during 95 percent artificial arterial stenosis. Surgery 121:411–418PubMedCrossRefGoogle Scholar
  10. 10.
    DeAngeles DA, Scott AM, McGrath AM, Korent VA, Rodenkirch LA, Conhaim RL, Harms BA (1997) Resuscitation from hemorrhagic shock with diaspirin cross-linked hemoglobin, blood, or hetastarch. J Trauma 42:406–412;PubMedCrossRefGoogle Scholar
  11. 11.
    Viele MK, Weiskopf RB, Fisher D (1997) Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics. Anesthesiology 86:848–858PubMedCrossRefGoogle Scholar
  12. 12.
    Przybelski RJ, Daily EK, Kisicki JC, Mattia Goldberg C, Bounds MJ, Colburn WA (1996) Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 24:1993–2000PubMedCrossRefGoogle Scholar
  13. 13.
    Jia L, Bonaventura J, Stamler JS (1996) S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380:221–226PubMedCrossRefGoogle Scholar
  14. 14.
    Kasper SM, Walter M, Grüne F, Bischoff A, Erasmi H, Buzello W (1996) Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 83:921–927PubMedGoogle Scholar
  15. 15.
    Dietz NM, Martin CM, Beltrandelrio AG, Joyner MJ (1997) The effects of cross linked hemoglobin on regional vascular conductance in dogs. Anesth Analg 85:265–273PubMedGoogle Scholar
  16. 16.
    Gulati A, Sharma AC, Singh G (1996) Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 24:137–147PubMedCrossRefGoogle Scholar
  17. 17.
    Gulati A, Rebello S (1994) Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin J Lab Clin Med 124:125–133PubMedGoogle Scholar
  18. 18.
    Gould SA, Moss GS (1996) Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg 20:1200–1207PubMedCrossRefGoogle Scholar
  19. 19.
    Keipert PE, Gomez CL, Gonzales A, MacDonald VW, Hess JR, Winslow RM (1994) Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 123:701–711PubMedGoogle Scholar
  20. 20.
    Bleeker WK, van der Pias J, Feitsma RI, Agterberg J, Rigter G, de Vries van Rossen A, Pauwels EK, Bakker JC (1989) In vivo distribution and elimination of hemoglobin modified by intramolecular cross-linking with 2-nor-2-formylpyridoxal 5′-phosphate. J Lab Clin Med 113:151–161PubMedGoogle Scholar
  21. 21.
    Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS (1993) A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 122:301–308PubMedGoogle Scholar
  22. 22.
    Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ (1997) Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 25:1480–1488PubMedCrossRefGoogle Scholar
  23. 23.
    Ma Z, Monk TG, Goodnough LT, McClellan A, Gawryl M, Clark T, Moreira P, Keipert PE, Scott MG (1997) Effect of hemoglobin- and Perflu-bron-based oxygen carriers on common clinical laboratory tests. Clin Chem 43:1732–1737PubMedGoogle Scholar
  24. 24.
    Riess JG (1992) Overview of progress in the fluorocarbon approach to in vivo oxygen delivery. Biomater Artif Cells Immobil Biotechnol 20:183–202Google Scholar
  25. 25.
    Wahr JA, Trouwborst A, Spence RK, Henny CP, Cernaianu AC, Graziano GP, Tremper KK, Flaim KE, Keipert PE, Faithfull NS, Clymer JJ (1996) A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth Analg 82:103–107PubMedGoogle Scholar
  26. 26.
    Young LH, Jaffe CC, Revkin JH, McNulty PH, Cleman M (1990) Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty. Am J Cardiol 65:986–990PubMedCrossRefGoogle Scholar
  27. 27.
    Kent KM, Cleman MW, Cowley MJ, Forman MB, Jaffe CC, Kaplan M, King SD, Krucoff MW, Lassar T, McAuley B, et al (1990) Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol. Am J Cardiol 66:279–284PubMedCrossRefGoogle Scholar
  28. 28.
    Keipert PE, Faithfull NS, Bradley JD, Hazard DY, Hogan J, Levisetti MS, Peters RM (1994) Oxygen delivery augmentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution. Adv Exp Med Biol 345:197–204PubMedCrossRefGoogle Scholar
  29. 29.
    Holman WL, Spruell RD, Ferguson ER, Clymer JJ, Vicente WV, Murrah CP, Pacifico AD (1995) Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass. J Thorac Cardiovasc Surg 110:774–785PubMedCrossRefGoogle Scholar
  30. 30.
    van Rossem K, Vermarien H, Faithfull NS, Wouters L, Decuyper K (1997) Effects of perflubron emulsion and 100% oxygen breathing on local tissue PO2 in brain cortex of unanaesthetized rabbits. Adv Exp Med Biol 411:403–409PubMedCrossRefGoogle Scholar
  31. 31.
    Stern SA, Dronen SC, McGoron AJ, Wang X, Chaffins K, Millard R, Keipert PE, Faithfull NS (1995) Effect of supplemental perfluorocarbon administration on hypotensive resuscitation of severe uncontrolled hemorrhage. Am J Emerg Med 13:269–275PubMedCrossRefGoogle Scholar
  32. 32.
    Manning JE, Batson DN, Payne FB, Adam N, Murphy CA, Perretta SG, Norfleet EA (1997) Selective aortic arch perfusion during cardiac arrest: enhanced resuscitation using oxygenated perflubron emulsion, with and without aortic arch epinephrine. Ann Emerg Med 29:580–587PubMedCrossRefGoogle Scholar
  33. 33.
    Keipert PE, Faithfull NS, Roth DJ, Bradley JD, Batra S, Jochelson P, Flaim KE (1996) Supporting tissue oxygenation during acute surgical bleeding using a perfluorochemical-based oxygen carrier. Adv Exp Med Biol 388:603–9PubMedCrossRefGoogle Scholar
  34. 34.
    Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR (1997) Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. An in vitro thrombelastography study. Br J Anaesth 78:684–689PubMedGoogle Scholar
  35. 35.
    A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy (1996) Practice guidelines for blood component therapy. Anesthesiology 84:732–747CrossRefGoogle Scholar
  36. 36.
    Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews AJ, Miller-Roerich J, Shoemaker S, Trimble S, Fermi G, Komiyama NH, Nagai K, Steuer GL (1992) A human recombinant haemoglobin designed for use as a blood substitute. Nature 356:258–260PubMedCrossRefGoogle Scholar
  37. 37.
    Dieryck W, Pagnier J, Poyart C, Marden MC, Gruber V, Bournat P, Baudino S, Merot B (1997) Human haemoglobin from transgenic tobacco. Nature 386:29–30PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • D. R. Spahn

There are no affiliations available

Personalised recommendations